Yosef Yarden
- Oncology top 2%
- HER2/EGFR in Cancer Research 11
- Cancer Cells and Metastasis 4
- Cancer Research top 2%
- Molecular Biology top 2%
- Glycosylation and Glycoproteins Research 5
- PI3K/AKT/mTOR signaling in cancer 4
- RNA Interference and Gene Delivery 3
- Cancer therapeutics and mechanisms 3
-
- Monoclonal and Polyclonal Antibodies Research 9
- Immunology and Allergy top 5%
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- A. UllrichJulian DownwardNicholas F. TottyJoseph SchlessingerE. L. V. MayesPeter A. StockwellMichael D. WaterfieldSabrina Strano
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Yosef Yarden
49 papers receiving 4.7k citations
Hit Papers
Peers
Comparison fields: 5 of 121
- Oncology 1.6k
- Cancer Research 765
- Molecular Biology 3.2k
- Radiology, Nuclear Medicine and Imaging 780
- Immunology and Allergy 176
Countries citing papers authored by Yosef Yarden
This map shows the geographic impact of Yosef Yarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yosef Yarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yosef Yarden more than expected).
Fields of papers citing papers by Yosef Yarden
This network shows the impact of papers produced by Yosef Yarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yosef Yarden. The network helps show where Yosef Yarden may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yosef Yarden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 9 | |
| 2 | 2022 | 1 | |
| 3 | 2021 | 2 | |
| 4 | 2020 | 40 | |
| 5 | 2020 | 38 | |
| 6 | 2020 | 39 | |
| 7 | 2018 | 43 | |
| 8 | 2018 | 26 | |
| 9 | 2018 | 93 | |
| 10 | 2017 | 42 | |
| 11 | 2015 | 38 | |
| 12 | 2014 | 2 | |
| 13 | 2013 | 37 | |
| 14 | 2008 | 72 | |
| 15 | 2007 | 89 | |
| 16 | Recycling of HER-ErbB Receptors: Rescue From Apoptosis and Targets for Immunotherapy | 2002 | 1 |
| 17 | 1995 | 142 | |
| 18 | 1993 | 31 | |
| 19 | 1992 | 145 | |
| 20 | Flg-2, a new member of the family of fibroblast growth factor receptors. | 1991 | 49 |
About Yosef Yarden
Yosef Yarden is a scholar working on Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, having authored 49 papers that have together received 4.9k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Lung Cancer Treatments and Mutations (6 papers), Glycosylation and Glycoproteins Research (5 papers), PI3K/AKT/mTOR signaling in cancer (4 papers), Cancer Cells and Metastasis (4 papers), RNA Interference and Gene Delivery (3 papers) and Cancer therapeutics and mechanisms (3 papers). The work is most often cited by research in Oncology (1.6k citations), Cancer Research (765 citations) and Molecular Biology (3.2k citations). Yosef Yarden has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include A. Ullrich, Julian Downward, Nicholas F. Totty, Joseph Schlessinger, E. L. V. Mayes, Peter A. Stockwell, Michael D. Waterfield, Sabrina Strano, Giovanni Blandino and Lorena Verduci. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.